カテゴリ： MarketLine, シンガポール, 企業調査

Olam International Ltd：戦略・SWOT・企業財務分析

◆英語タイトル：Olam International Ltd - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA8015080
◆発行会社（調査会社）：MarketLine
◆発行日：2017年9月30日
◆ページ数：46
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：シンガポール
◆産業分野：消費財
◆販売価格オプション（消費税別）
Single UserUSD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Olam International Ltd – Strategy, SWOT and Corporate Finance Report
Summary

Olam International Ltd – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Olam International Limited (Olam) is a global producer and processor of agricultural products and food ingredients. The company is involved in sourcing, primary processing, packaging and marketing of agricultural products and food ingredients. Olam’s product portfolio includes edible nuts, spices, beans, confectionery, beverage ingredients, food staples, packaged foods, and industrial raw materials. The company is also involved in commodity financial services and fund management businesses. It supplies foods and industrial raw materials to customers across Asia, West and Central Africa, East Africa, Southern Africa, Middle East and North Africa, North America, Central America, South America, Europe, and Australia. Olam is headquartered in Singapore City, Singapore.

Scope

- Detailed information on Olam International Ltd required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Olam International Ltd in the form of a SWOT analysis
- An in-depth view of the business model of Olam International Ltd including a breakdown and examination of key business segments
- Intelligence on Olam International Ltd’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Olam International Ltd, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Olam International Ltd and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Olam International Ltd as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Olam International Ltd’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Olam International Ltd: Company Overview
Olam International Ltd: Overview and Key Facts
Olam International Ltd: Overview
Olam International Ltd: Key Facts
Olam International Ltd: Key Employees
Olam International Ltd: Key Employee Biographies
Olam International Ltd: Major Products and Services
Olam International Ltd: Company History
Olam International Ltd: Management Statement
Olam International Ltd: Locations and Subsidiaries
Olam International Ltd: Key Competitors
Olam International Ltd: Company Analysis
Olam International Ltd: Business Description
Olam International Ltd: SWOT Analysis
Olam International Ltd: SWOT Overview
Olam International Ltd: Strengths
Olam International Ltd: Weaknesses
Olam International Ltd: Opportunities
Olam International Ltd: Threats
Olam International Ltd: Corporate Financial Deals Activity
Olam International Ltd: Financial Deals Overview
Olam International Ltd: Targets and Partners
Olam International Ltd: Top Deals 2013 – 2017YTD*
Olam International Ltd: Advisors
Olam International Ltd: Top Financial Advisors
Olam International Ltd: Mergers and Acquisitions
Olam International Ltd: Capital Raising
Olam International Ltd: Partnership
Olam International Ltd: Divestments
Olam International Ltd: Private Equity and Ownership
Olam International Ltd: Recent Developments
Olam International Ltd: News and Events Summary
Olam International Ltd: Business Expansion
Olam International Ltd: Corporate Governance
Olam International Ltd: Financial Deals
Olam International Ltd: Financial Performance
Olam International Ltd: Regulatory and Legal Events
Olam International Ltd: Strategy and Operations
Appendix
Contact Us
Methodology
Definitions
About MarketLine

List of Tables
Table 1: Olam International Ltd: Key Facts
Table 2: Olam International Ltd: Key Employees
Table 3: Olam International Ltd: Locations and Subsidiaries
Table 4: Olam International Ltd: Key Competitors
Table 5: Olam International Ltd: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Olam International Ltd: Deal Activity by Deal Type - Volume (2013 - YTD*2017)
Table 7: Olam International Ltd: M&A Average Deal Size - Value (US$m)
Table 8: Olam International Ltd: Targets and Partners
Table 9: Olam International Ltd: Top Deals 2013 - 2017YTD*
Table 10: Olam International Ltd: Financial Advisor Ranking by Value (US$m)
Table 11: Olam International Ltd: M&A Volume and Value Trend (2013 - YTD*2017)
Table 12: Olam International Ltd: M&A Activity by Geography (2013 - YTD*2017)
Table 13: Olam International Ltd: Capital Raising Volume and Value Trend (2013 - YTD*2017)
Table 14: Olam International Ltd: Capital Raising by Deal Type (2013 - YTD*2017)
Table 15: Olam International Ltd: Partnership Volume and Value Trend (2013 - YTD*2017)
Table 16: Olam International Ltd: Partnership Trend by Deal Type (2013 - YTD*2017)
Table 17: Olam International Ltd: Divestments Volume and Value Trend (2013 - YTD*2017)
Table 18: Olam International Ltd: Divestments by Geography (2013 - YTD*2017)
Table 19: Olam International Ltd: Private Equity and Ownership Volume and Value Trend (2013 - YTD*2017)
Table 20: Olam International Ltd: Private Equity and Ownership Volume by Deal Type (2013 - YTD*2017)
Table 21: Olam International Ltd: News and Events Summary
Table 22: Olam International Ltd: Business Expansion
Table 23: Olam International Ltd: Corporate Governance
Table 24: Olam International Ltd: Financial Deals
Table 25: Olam International Ltd: Financial Performance
Table 26: Olam International Ltd: Regulatory and Legal Events
Table 27: Olam International Ltd: Strategy and Operations

★海外企業調査レポート[Olam International Ltd：戦略・SWOT・企業財務分析]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Sequa Corporation：企業の戦略・SWOT・財務情報
    Sequa Corporation - Strategy, SWOT and Corporate Finance Report Summary Sequa Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • MDNA Life Sciences Inc-医療機器分野：企業M&A・提携分析
    Summary MDNA Life Sciences Inc (MDNA) is a molecular diagnostics company that develops molecular tests based on the mitochondrial genome. The company’s prostate core mitomic test (PCMT) based on the science of mitochondrial DNA (mtDNA) is a tissue-based prostate cancer diagnostics for prostate and o …
  • Assore Limited：企業の戦略・SWOT・財務分析
    Assore Limited - Strategy, SWOT and Corporate Finance Report Summary Assore Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Fluor Corporation (FLR)-エネルギー分野：企業M&A・提携分析
    Summary Fluor Corporation (Fluor) is a provider of engineering and construction services. The company's service portfolio includes design, engineering, procurement, fabrication, modularization, construction, commissioning and maintenance, and project management solutions. Fluor also offers other ser …
  • Immuron Ltd (IMC)：企業の財務・戦略的SWOT分析
    Summary Immuron Ltd (Immuron), formerly Anadis Ltd is a biopharmaceutical company that develops oral immunotherapy therapeutics using polyclonal antibody products for humans. The company develops and produces an orally stable therapeutic for various immune mediated and inflammatory disorders. It pro …
  • FMT Aircraft Gate Support Systems AB：企業の戦略・SWOT・財務情報
    FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report Summary FMT Aircraft Gate Support Systems AB - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • FOX Broadcasting Co：企業の戦略的SWOT分析
    FOX Broadcasting Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • China Shipbuilding Industry Corp：企業の戦略・SWOT・財務情報
    China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report Summary China Shipbuilding Industry Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • SBM Offshore NV (SBMO)：企業の財務・戦略的SWOT分析
    SBM Offshore NV (SBMO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Apogenix AG-製薬・医療分野：企業M&A・提携分析
    Summary Apogenix AG (Apogenix) is a biopharmaceutical company, developing immuno-oncology medicines for the treatment of cancer and other malignant diseases. Its pipeline drug candidates under clinical development include Asunercept (APG101), a CD95 ligand inhibitor, for the treatment of glioblastom …
  • Kuwait Gulf Oil Co：企業の戦略的SWOT分析
    Kuwait Gulf Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Opus Energy Group Ltd：企業の戦略的SWOT分析
    Opus Energy Group Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Oil & Gas Development Co Ltd (OGDC)
    Oil & Gas Development Co Ltd (OGDC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Magellan Midstream Partners, L.P.：企業の戦略・SWOT・財務情報
    Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report Summary Magellan Midstream Partners, L.P. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, pro …
  • Societe Nationale Industrielle et Miniere：企業の戦略・SWOT・財務情報
    Societe Nationale Industrielle et Miniere - Strategy, SWOT and Corporate Finance Report Summary Societe Nationale Industrielle et Miniere - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SW …
  • Genzyme Corp-医療機器分野：企業M&A・提携分析
    Summary Genzyme Corp (Genzyme), a subsidiary of Sanofi, is a biotechnology company that develops specialty treatments targeting rare and special unmet medical needs. Its product pipeline comprises Dupilumab for atopic dermatitis and asthma; Patisiran for familial amyloid polyneuropathy; Isatuximab f …
  • Guangzhou Wondfo Biotech Co Ltd (300482)-医療機器分野：企業M&A・提携分析
    Summary Guangzhou Wondfo Biotech Co Ltd (Wondfo) is a biological company that provides rapid diagnostic services. The company manufactures medical products and biochemical reagents. Its products include rapid test, immunofluorescent test system, glucose monitoring system, and raw materials. Wondfo a …
  • Swedish Orphan Biovitrum AB (SOBI)：企業の財務・戦略的SWOT分析
    Swedish Orphan Biovitrum AB (SOBI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Catalyst Biosciences Inc (CBIO)：企業の財務・戦略的SWOT分析
    Summary Catalyst Biosciences Inc (Catalyst Biosciences) is a clinical-stage biopharmaceutical company that develops protease-based advanced medicines to treat hematological indications. The company specializes in hemostasis, with focus on subcutaneous prophylaxis of hemophilia and surgery, and anti- …
  • Black Hills Corporation (BKH)：電力：M&Aディール及び事業提携情報
    Summary Black Hills Corporation (BHC) is a vertically-integrated energy company which offers electricity and natural gas. The company produces, transmits, and distributes electricity; and sells natural gas on retail and wholesale basis. It generates electricity from natural gas, coal, diesel oil, an …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆